Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Shanghai Pulmonary Hospital

InstitutionResearch output, impact & collaborations

Shanghai Pulmonary Hospital is a research organisation in Shanghai, CN. OpenAlex records 8,293 works and 759,341 citations for it. 2,742 researchers list it as their most recent affiliation.

8,293
Works
759,341
Citations
2,742
Researchers
27.5
Avg h-index

How has Shanghai Pulmonary Hospital's publication output changed over time?

ScholarIQpublication output · 2016–2022

Output declined50% over the shown period — from 2 works in 2016 to 1 in 2022.

2
2
3
1
1
2
1
2016201720182019202020212022

Who are the most-cited researchers behind Shanghai Pulmonary Hospital?

ScholarIQtop researchers by citations
1
Tao Jiang · Cancer Immunotherapy and Biomarkers
348 works8,979 citations
2
Xinlong Zheng · Lung Cancer Diagnosis and Treatment
34 works98 citations

What are the most-cited papers on Shanghai Pulmonary Hospital?

ScholarIQmost cited works
Role of IL-2 in cancer immunotherapy
Tao Jiang, Caicun Zhou, Shengxiang Ren
S2497914550. 2016549 CitationsOPEN ACCESS
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
Zhe Yang, Nong Yang, Qiuxiang Ou, Yi Xiang, Tao Jiang, Xue Wu, Hua Bao, Xiaoling Tong, Xiaonan Wang, Yang Shao, Yunpeng Liu, Yan Wang, Caicun Zhou
Clinical Cancer Research. 2018549 Citations
TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway
Guohe Song, Shifeng Xu, Hong Zhang, Yupeng Wang, Chao Xiao, Tao Jiang, Leilei Wu, Tao Zhang, Xing Sun, Lin Zhong, Chongzhi Zhou, Zhao‐Wen Wang, Zhihai Peng, Jian Chen, Xiaoliang Wang
Journal of Experimental & Clinical Cancer Research. 2016376 CitationsOPEN ACCESS
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer
Sha Zhao, Shengxiang Ren, Tao Jiang, Bo Zhu, Xuefei Li, Chao Zhao, Yijun Jia, Jinpeng Shi, Limin Zhang, Xiaozhen Liu, Meng Qiao, Xiaoxia Chen, Chunxia Su, Hui Yu, Caicun Zhou, Jun Zhang, D. Ross Camidge, Fred R. Hirsch
S2765010658. 2019336 Citations
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
Shengxiang Ren, Jianhua Chen, Xingxiang Xu, Tao Jiang, Ying Cheng, Gongyan Chen, Yueyin Pan, Yong Fang, Qiming Wang, Yunchao Huang, Wenxiu Yao, Rui Wang, Xingya Li, Wei Zhang, Yanjun Zhang, Sheng Hu, Renhua Guo, Jianhua Shi, Zhiwu Wang, Peiguo Cao, Donglin Wang, Jian Fang, Hui Luo, Yi Geng, Chunyan Xing, Dongqing Lv, Yiping Zhang, Junyan Yu, Shundong Cang, Zeyu Yang, Wei Shi, Jianjun Zou, Caicun Zhou
Journal of Thoracic Oncology. 2021320 Citations

How much of the research on Shanghai Pulmonary Hospital is open access?

ScholarIQopen access share
42%OPEN ACCESS
Gold
33%
Green
0%
Hybrid
8%
Bronze
0%
Closed
58%

Related on ScholarIQ

Lung Cancer Treatments and Mutations
Top Topic
Lung Cancer Diagnosis and Treatment
Top Topic
Cancer Immunotherapy and Biomarkers
Top Topic
Lung Cancer Research Studies
Top Topic
Tuberculosis Research and Epidemiology
Top Topic
Pulmonary Hypertension Research and Treatments
Top Topic
470M+ articles · free account